Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged syringe, 4) One 20-gauge 1-inch needle, 5) Two 20-gauge 1.5-inch safety needles, 6) Two 20-gauge 2-inch safety needles. Rx Only. Manufactured and marketed by: Alkermes, Inc. Kit NDC: 65757-300-01
Published October 9, 2019 · Recall initiated: September 26, 2019
Summary
FDA records drug Class II recall D-0119-2020, published October 9, 2019 and initiated September 26, 2019. Recalling firm: Alkermes, Inc.; Status: Terminated; Reported quantity: 16,231 kits; Lot: Lot 2019-1002T, 2019-1003T, Exp 05/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.
What to do
Voluntary: Firm initiated · Letter
Get an email if VIVITROL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VIVITROL
- Manufacturer
- Alkermes, Inc.
- Distributor
- Nationwide USA and Canada
- Lot
- Lot 2019-1002T, 2019-1003T, Exp 05/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAIsoproterenol HCL (PF) in D5W, 200 mcg / 50 mL (4 mcg/mL), 50 mL IV Bag, Single Dose Only, Contains Sulfites,October 9, 2019
- FDALosartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 tablets per bottle, Rx Only, ManufacturedOctober 9, 2019
- FDACyclopentolate HCl 1% (10 mg/mL) / Phenylephrine HCl 10% (100 mg/mL) / Tropicamide 1% (10 mg/mL) / KetorolacOctober 9, 2019
- FDAHy-Vee Mealtime Fried Rice in a 16 oz. black plastic container with clear plastic lidOctober 9, 2019
- FDAVIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX OnlySeptember 3, 2014
- FDAVIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mgJuly 31, 2013
Questions about this recall
Was Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged syringe, 4) One 20-gauge 1-inch needle, 5) Two 20-gauge 1.5-inch safety needles, 6) Two 20-gauge 2-inch safety needles. Rx Only. Manufactured and marketed by: Alkermes, Inc. Kit NDC: 65757-300-01 recalled?
Yes. FDA published recall D-0119-2020 on October 9, 2019. Reported hazard: Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VIVITROL.